Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000930413-15-003024
Filing Date
2015-07-07
Accepted
2015-07-07 16:15:35
Documents
1
Effectiveness Date
2015-07-07
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12960
  Complete submission text file 0000930413-15-003024.txt   14041
Mailing Address 1375 TRANS-CANADA HIGHWAY SUITE 200 DORVAL A8 H9P 2W8
Business Address 1375 TRANS-CANADA HIGHWAY SUITE 200 DORVAL A8 H9P 2W8 (514) 940-3600
Clementia Pharmaceuticals Inc. (Filer) CIK: 0001647320 (see all company filings)

EIN.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-243197 | Film No.: 15976741